Transcatheter heart valves technologies

Coronary artery disease and TAVI: Current evidence on a recurrent issue

Published on 20/04/2023 | Mauro MassussiMD 1 et al. | Catheterization and Cardiovascular Interventions 2023; AOP: 10.1002/ccd.30653 | 16 minute read

Abstract Coronary artery disease (CAD) is a frequent finding in patients with aortic stenosis (AS). Concomitant coronary artery bypass and

Transcatheter heart valves technologies

Transcatheter edge-to-edge mitral valve repair in mitral regurgitation: current status and future prospects

Published on 06/04/2023 | Lukas Stolz a et al. | Expert Review of Medical Devices 2023; 20(2): 99-108 | 0 minute read

Transcatheter heart valves technologies

Comparison of patients with bicuspid and tricuspid aortic valve in transcatheter aortic valve implantation

Published on 16/03/2023 | Zhongkai Zhu a et al. | Expert Review of Medical Devices 2023; aop:10.1080/17434440.2023.2184686 | 0 minute read

Transcatheter heart valves technologies

Outcomes with plug‐based versus suture‐based vascular closure device after transfemoral transcatheter aortic valve replacement: A systematic review and meta‐analysis

Published on 16/03/2023 | Ramy SedhomMD 1 et al. | Catheterization and Cardiovascular Interventions 2023; AOP: 10.1002/ccd.30597 | 21 minute read

Abstract Background Studies comparing plug‐based (i.e., MANTA) with suture‐based (i.e., ProStar XL and ProGlide) vascular closure devices (VCDs) for large‐bore

Transcatheter heart valves technologies

Gender-related differences on outcome following transcatheter mitral valve repair (TMVR): a systematic review and meta-analysis

Published on 02/03/2023 | Yi Kang 1 et al. | Journal of Cardiothoracic Surgery 2023; 18(1): 31 | 20 minute read

Abstract Background The effect of gender on patients with mitral valve regurgitation (MR) undergoing transcatheter mitral valve repair (TMVR) remains

Transcatheter heart valves technologies

Iliofemoral artery predilation prior to transfemoral transcatheter aortic valve implantation in patients with aortic valve stenosis and advanced peripheral artery disease

Published on 16/02/2023 | Hector A. Alvarez‐CovarrubiasMD 1 et al. | Catheterization and Cardiovascular Interventions 2023; AOP: 10.1002/ccd.30576 | 20 minute read

Abstract Objectives To investigate the feasibility and safety of percutaneous transluminal angioplasty (PTA) of the iliofemoral arteries (IFA) before transfemoral

Transcatheter heart valves technologies

Redo-Transcatheter Aortic Valve Implantation Using the SAPIEN 3/Ultra Transcatheter Heart Valves—Expert Consensus on Procedural Planning and Techniques

Published on 16/02/2023 | Tarantini et al. | The American Journal of Cardiology 2023; aop:10.1016/j.amjcard.2023.01.010 | 0 minute read

Transcatheter heart valves technologies

Short- to mid-term outcomes after transcatheter aortic valve replacement in patients with ascending aorta dilation: a single-centre retrospective analysis

Published on 02/02/2023 | Yu Jun et al. | BMC Cardiovascular Disorders 2023; 23(1): 31 | 18 minute read

Abstract Objectives Ascending aorta dilation (AAD) is frequently associated with aortic stenosis (AS). This study investigated the procedural and clinical

Transcatheter heart valves technologies

Peri‐procedural management of transcatheter mitral valve replacement in patients with heart failure

Published on 19/01/2023 | Sara L.Hungerford 1 et al. | European Journal of Heart Failure 2022; AOP: 10.1002/ejhf.2758 | 34 minute read

Abstract Over the past decade, transcatheter mitral valve replacement (TMVR) technologies have evolved with the objective of improving outcomes for

Transcatheter heart valves technologies

Minimum-incision trans-subclavian transcatheter aortic valve replacement with regional anesthesia

Published on 19/01/2023 | Domoto et al. | Journal of Cardiology 2023; 81(2): 131-7 | 0 minute read

This bibliographical database is provided by GNM Healthcare Group Companies USA, Inc. in full editorial independence.

The information published within the framework of this service may discuss or suggest certain therapies that have not been validated by the competent national authorities.
Service exclusively reserved for healthcare professionals.